Early Phase 1 Vascular Diseases Clinical Trials

3 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–3 of 3 trials

Recruiting

Early Phase 1

Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support

Vascular Diseases

Montefiore Medical Center50 enrolled1 locationNCT06510322

Recruiting

Early Phase 1

Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure

Cardiovascular DiseasesHypertension

University of Minnesota80 enrolled1 locationNCT06507657

Recruiting

Early Phase 1

Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease

Peripheral Arterial DiseasePeripheral Vascular DiseasesPeripheral Artery Disease

University of Nebraska20 enrolled1 locationNCT06319339